Applying machine learning in screening for Down Syndrome in both trimesters for diverse healthcare scenarios
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Population and Quantitative Health SciencesDocument Type
Journal ArticlePublication Date
2024-07-15
Metadata
Show full item recordAbstract
Background: This paper describes the development of low-cost, effective, non-invasive machine learning-based prediction models for Down Syndrome in the first two trimesters of pregnancy in Vietnam. These models are adaptable to different situations with limited screening capacities at community-based healthcare facilities. Method: Ultrasound and biochemical testing alone and in combination, from both trimesters were employed to build prediction models based on k-Nearest Neighbor, Support Vector Machine, Random Forest, and Extreme Gradient Boosting algorithms. Results: A total of 7,076 pregnant women from a single site in Northern Vietnam were included, and 1,035 had a fetus with Down Syndrome. Combined ultrasound and biochemical testing were required to achieve the highest accuracy in trimester 2, while models based only on biochemical testing performed as well as models based on combined testing during trimester 1. In trimester 1, Extreme Gradient Boosting produced the best model with 94% accuracy and 88% AUC, while Support Vector Machine produced the best model in trimester 2 with 89% accuracy and 84% AUC. Conclusions: This study explored a range of machine learning models under different testing scenarios. Findings point to the potential feasibility of national screening, especially in settings without enough equipment and specialists, after additional model validation and fine tuning is performed.Source
Do HD, Allison JJ, Nguyen HL, Phung HN, Tran CD, Le GM, Nguyen TT. Applying machine learning in screening for Down Syndrome in both trimesters for diverse healthcare scenarios. Heliyon. 2024 Jul 15;10(15):e34476. doi: 10.1016/j.heliyon.2024.e34476. PMID: 39144940; PMCID: PMC11320142.DOI
10.1016/j.heliyon.2024.e34476Permanent Link to this Item
http://hdl.handle.net/20.500.14038/53777PubMed ID
39144940Rights
© 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).; Attribution 4.0 InternationalDistribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.1016/j.heliyon.2024.e34476
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as © 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).